Showing results (971-980 of 9,032) with videos related to

Sort By:
Pageof 904
Journal of Biochemistry|March 1, 1983
Transglycosylation activities of exo- and endo-type cellulases from Irpex lacteus (Polyporus tulipiferae)T Kanda, I Noda, K Wakabayashi, et al.
Nucleic Acids Research|April 11, 1984
A simple and convenient synthesis of 3'-5'- or 2'-5'-linked oligoribonucleotide by polymerization of unprotected ribonucleoside using phosphorus tris-azoleT Shimidzu, K Yamana, N Kanda, et al.
Archivum Histologicum Japonicum = Nihon Soshikigaku Kiroku|January 1, 1977
Catecholamine-storing cells in the cyclostome heartN Otsuka, J Chihara, H Sakurada, et al.
Archives of Biochemistry and Biophysics|August 1, 1997
Arginase of Bacillus brevis Nagano: purification, properties, and implication in gramicidin S biosynthesisM Kanda, K Ohgishi, T Hanawa, et al.
Japanese Journal of Ophthalmology|December 21, 2005
A nontraumatic macular hole in a 10-year-old girlTetsuro Nakano, Akinori Uemura, Shigeru Kanda, et al.
The Biochemical Journal|December 22, 2005
Molecular and functional characterization of a novel gonadotropin-releasing-hormone receptor isolated from the common octopus (Octopus vulgaris)Atsuhiro Kanda, Toshio Takahashi, Honoo Satake, et al.
Biological & Pharmaceutical Bulletin|July 13, 2025
Prenatal Acetamiprid Exposure Enhances Microglial Activation in Primary Microglia CultureChristine Li Mei Lee, Yasunari Kanda, Sachiko Yoshida
Dermatitis : Contact, Atopic, Occupational, Drug|April 29, 2025
The Transition of Blood Biomarkers During 96-Week Treatment with Upadacitinib for Atopic Dermatitis: A Real-World Analysis Stratified by AgeTeppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Annals of Dermatology|April 1, 2025
Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical PracticeTeppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|May 15, 2025
Clinical and Laboratory Indexes for Predicting Early and Late Responders to Lebrikizumab in Atopic Dermatitis: A Prospective Cohort Observational StudyTeppei Hagino, Hidehisa Saeki, Eita Fujimoto, et al.
Pageof 904